Hyperacidity, GERD, and ulcers:
Indications for Nizatidine Capsules:
Active duodenal ulcer. Maintenance of healed duodenal ulcer. Benign gastric ulcer. Gastroesophageal reflux disease (GERD): including heartburn and erosive and ulcerative esophagitis.
Active duodenal or benign gastric ulcer: 300mg daily at bedtime or 150mg twice daily, both for up to 8 weeks. Maintenance: 150mg daily at bedtime. GERD: 150mg twice daily for up to 12 weeks. Renal impairment (CrCl ≤50mL/min): reduce dose (see full labeling).
<12yrs: not established. Use oral soln. Erosive esophagitis, GERD (≥12yrs): 150mg twice daily for up to 8 weeks; max 300mg/day. Renal impairment (CrCl ≤50mL/min): reduce dose (see full labeling).
Nizatidine Capsules Warnings/Precautions:
Rule out malignant gastric ulceration. Renal impairment. Elderly. Pregnancy (Cat.B). Nursing mothers: not recommended.
Nizatidine Capsules Classification:
Nizatidine Capsules Interactions:
May elevate serum salicylate levels in high-dose aspirin patients.
Headache, anemia, diarrhea, dizziness, sweating, rhinitis, urticaria.
Formerly known under the brand name Axid.